Drug intelligence / Profile preview

GCA 2700

Development stage
Unknown
Lead developer
Santé Verte Laboratoires
Modality
Small Molecules
Administration
Oral
01

Overview

GCA 2700® is a multi-ingredient dietary supplement developed by Santé Verte Laboratoires designed to support joint health, flexibility, and comfort. The formulation is a complex of six active ingredients: glucosamine sulfate and chondroitin sulfate, which are key structural components of cartilage; methylsulfonylmethane (MSM), which provides organic sulfur; turmeric extract (Curcuma longa), utilized for its role in maintaining tendon and joint flexibility; harpagophytum (devil's claw), used for mobility; and hyaluronic acid, a component of synovial fluid that supports joint lubrication. It is primarily indicated for individuals experiencing age-related joint issues or symptoms associated with arthritis. Clinical evaluations conducted by Mérieux Nutrisciences demonstrated that 84% of consumers reported satisfaction with the product after three months of use, as assessed by the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) score.

Brand names
GCA 2700GCA2700GCA-2700
Other names
GCA 2700 Santé Verte
02

Targets

PTGS2 (Prostaglandin-Endoperoxide Synthase 2)

Beyond the preview

Go deeper on GCA 2700.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on GCA 2700.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call